Aurobindo Pharma has acquired the Generis group in Portugal (subject to the fulfilment of certain anti-trust approvals), through its step down subsidiary Agile Pharma (Netherlands) for a consideration of €135 million (Rs. 985 crore). The consideration is proposed to be financed via European debt
3.29 PM Jan 18th
and the business from their UVA points 25000 of them. Agreement with OLA how much additional revenues it will garner for the company in future. The proposed court case going on in portugal and the amount to be recd if the company wins the case and how much time it will take 10 years have gone by and all cases
10.17 PM Jan 11th
, Dani said. Currently, Aurobindo is among the top 10 generic players in seven European countries namely Portugal, Netherlands, France, Germany, Belgium, Spain and Italy. Aurobindo has shareholder approval to raise Rs 2,100 crore through a sale of shares, which it intends to use for global acquisitions
9.51 PM Jan 10th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.